Hubei Bafeng is one of the national pharmaceutical amino acid industrialization bases in China, with over 20 drug approval numbers;
After the acquisition is completed, Grand Pharma will become the pharmaceutical company with the most registration numbers of amino acid APIs in China;
Grand Pharma's amino acid industry has leading technological advantages, and its products are sold to more than 140 countries and regions around the world.
